SARS-CoV-2: What is known and what there is to know - Focus on coagulation and lipids Hospitalized patients should then have coagulation tests performed at admission in order to identify stratify risk in swab-positive patients or even identify those yet "unrecognized". As reported above, SARS-CoV-2 patients with troponin levels in the higher range (and less favourable outcomes) have higher triglyceride levels and - hypothetically - an overflow of circulating triglycerides with detrimental effect on endothelial biology, especially in the postprandial state. As the stress on intensive therapies is easing, there is an increasing need to focus on asymptomatic SARS-CoV-2 infection, which should not be limited to its infectivity but extended to potential unrecognized clinical features and long-term effects/normalization of coagulation and lipid disorders. [Extracted from the article]